US Patent 11129817 Solid dispersion forms of rifaximin

Patent 11129817 was granted and assigned to Salix Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Salix Pharmaceuticals

Current Assignee

‌

Salix Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111298170

Patent Inventor Names

Mohammed A. Kabir0

Pam Golden0

Date of Patent

September 28, 2021

Patent Application Number

202102120

Date Filed

February 12, 2021

Patent Citations Received

‌

US Patent 11311521 Solid dispersion forms of rifaximin

Patent abstract

Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11129817 Solid dispersion forms of rifaximin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API